Pentavalent Antimony

DB13047InvestigationalSmall molecule

Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.

Chemical structure of Pentavalent Antimony
Formula / weight
Sb · 121.757 g/mol (avg)
Also known as
SB5+

Resolves to

Compound
UNII841L03HG64CAS22537-51-5PubChem73608879
Clinical / RWD
RxNorm1546283
Structure
InChIKeyZDINGUUTWDGGFF-UHFFFAOYSA-NSMILES[Sb+5]

What you can answer from here — as of April 02, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Pentavalent Antimony, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In